Host Cationic Antimicrobial Molecules Inhibit S. aureus Exotoxin Production

Area of Science:

• Immunology
• Microbiology
• Biochemistry

Background:

• Staphylococcus aureus is a major human pathogen responsible for millions of infections annually.
• Innate immune molecules, such as defensins and lysozyme, are found on mucosal and skin surfaces.
• These molecules are known to poorly inhibit or not inhibit S. aureus growth.

Purpose of the Study:

• To investigate the effect of innate immune molecules on Staphylococcus aureus exotoxin production.
• To determine the mechanism of action for inhibition of exotoxin production by these molecules.

Main Methods:

• Assessed the impact of human neutrophil α-defensin-1 (HNP-1), human β-defensin 1 (HBD-1), lysozyme, and S100A8/A9 on S. aureus exotoxin production.
• Measured inhibition of hemolysins and superantigens at various concentrations.
• Investigated the role of the SrrA/B two-component system in the inhibitory effects.

Main Results:

• HNP-1 and lysozyme significantly inhibited S. aureus exotoxin production (hemolysins and superantigens) at sub-growth inhibitory concentrations.
• HBD-1 inhibited hemolysin but not superantigen production.
• S100A8/A9 enhanced exotoxin production at high concentrations, while EDTA inhibited exotoxin production only at concentrations that also inhibited growth.

Conclusions:

• The primary activity of innate immune peptides like defensins and lysozyme against S. aureus is the inhibition of exotoxin production, not growth.
• This inhibition of virulence factors is crucial for controlling S. aureus colonization and pathogenesis.
• Targeting exotoxin production represents a potential therapeutic strategy against S. aureus infections.